Subscribe to Newsletter

Diagnostics

Diagnostics Genetics and epigenetics

A Personalized Reality

| Matthew Smith , George Burghel

Next generation sequencing holds much promise for personalized cancer diagnosis, treatment and management, but how is this being realized and what does the future hold?

Diagnostics Oncology

Buying the Hype

| Michael Schubert

As consumer genetic testing becomes cheaper and easier to access, medical professionals worry that unregulated Internet marketing may steer patients in the wrong direction

Diagnostics Regulation and standards

Hitting the Mark

| Roisin McGuigan

New US guidelines for colorectal cancer testing highlight the importance of molecular markers

Diagnostics Biochemistry and molecular biology

Benchmarking Biomarkers of Myocardial Infarction

| Roisin McGuigan

What does analysis of the last five years of literature on myocardial infarction biomarkers tell us about the priorities of this field of research and the major contributors to it?

Diagnostics Biochemistry and molecular biology

Illuminating IBD

| Roisin McGuigan

Zebrafish studies uncover a potential molecular trigger of inflammatory bowel disease

Diagnostics Microscopy and imaging

Piecing Together the Protein Puzzle

| Michael Schubert

New imaging techniques allow researchers to watch protein translation, movement and interaction within the cell

Diagnostics Biochemistry and molecular biology

A new ERA for IVF?

| Roisin McGuigan

Molecular testing of an endometrial biopsy could help fertility specialists choose the perfect time for embryo implantation

Diagnostics Digital and computational pathology

Pioneers of Precision

| Jeremy Nicholson, Ron M. A. Heeren, Steven Olde Damink

Jeremy Nicholson shares the vision behind the UK’s MRC-NIHR National Phenome Centre, Ron Heeren showcases the new M4I institute and Steven Olde Damink offers the surgeon’s perspective as a new age of healthcare dawns.

Diagnostics Biochemistry and molecular biology

Targeted Metabolomics

| Hannah Noel

Should tandem mass spectrometry be used in the screening of inborn errors of metabolism?

Diagnostics Training and education

How Will the Updated HER2 Guidance Affect You?

| Roisin McGuigan

Revised guidelines call for increased accuracy and greater pathologist-oncologist collaboration, but will impact workload

Register to The Pathologist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Pathologist magazine

Register